Group items tagged

Increasing Focus on Aesthetic Appeal and Growing Geriatric Population to Augment Growth of Skin Rejuvenation Devices Market Skin rejuvenation is basically a cosmetic surgery, which aims to bring about a more youthful appearance of the face. Various facial rejuvenation techniques can be used to accomplish this goal. Such procedures can range in depth and Invasiveness of treatment. It is important for you to understand the kind of skin care treatment that would be best suited for your specific goals and preferences. Increasing focus on aesthetic appeal is expected to propel growth of the skin rejuvenation devices market. For instance, according to a 2018 survey by Global Data, around three quarters of South Korean men undertake a beauty or grooming treatment at least once a week. Moreover, increasing geriatric population is also expected to aid in growth of the market. For instance, according to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034. Increasing expenditure on personal care products is expected to offer lucrative growth opportunities for players in the skin rejuvenation devices market. For instance, according to the U.S. Bureau of Labor Statistics, average annual expenditure on personal care products in the U.S. increased from US$ 707 in 2016 to US$ 768 in 2018. Read more @ https://coherentmarketinsights-blog.blogspot.com/2020/12/increasing-focus-on-aesthetic-appeal.html

Dementia is one of the most common age-related medical conditions. As we age, mental processes and memory become affected by changes in the brain, resulting in problems with memory, attention, mood, and behavior. Dementia can occur in anyone, although it is more common in elderly adults and people suffering from other mental disorders such as depression, bipolar disorder, schizophrenia, obsessive-compulsive disorder, and post-traumatic stress disorder. High prevalence of dementia is expected to propel growth of the dementia drugs market. For instance, according to Alzheimer's Association, around 5.8 million people in the U.S. aged 65 and older are living with Alzheimer's dementia in 2020. Moreover, increasing geriatric population is also expected to aid in growth of the market. For instance, according to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034. Read more @ https://sachinbhombe.blogspot.com/2021/03/high-prevalence-of-dementia-and-r-of.html

Nutricosmetics refers to nutritional supplements that are used to enhance aesthetic appeal. Skin care usually includes the application of creams, lotions and other skin products. Nutricosmetics can be used to make skin look younger and healthier. The ingredients used to make these products usually include vitamins, antioxidants, and other nutrients that the skin needs to function properly. There are other forms that can be used in making the skin look younger. Increasing aesthetic appeal is expected to propel growth of the nutricosmetics market. For instance, according to a 2018 survey by GlobalData, around three quarters of South Korean men undertake a beauty or grooming treatment at least once a week. Moreover, increasing geriatric population is also expected to aid in growth of the market. For instance, according to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034. Increasing expenditure on personal care products is expected to offer lucrative growth opportunities for players in the nutricosmetics market. For instance, according to the U.S. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/03/increasing-aesthetic-appeal-and.html

Increasing adoption of smartphones is expected to propel growth of the global online retail market. For instance, according to Pew Research Center, as of February 2019, 81% of U.S. adults used smartphones compared to 77% in October 2018. Moreover, increasing penetration of internet is also expected to aid in growth of the market. For instance, according to China government-backed Market Intelligence & Consulting Institute and reported by China Internet Watch, internet penetration in China reached 61.2 percent in the first half of 2019, with 854 million internet users at the end of June 2019. Emergence of Covid-19 is expected to offer lucrative growth opportunities for players in the global online retail market. For instance, in July 2020, Columbia Sportswear Company reported a 40% decline in overall net revenues in its July 2020 quarterly earnings report, due in part to pandemic-related store closures. However, the company's e-commerce sales increased 72% compared with the year-ago period. Moreover, increasing expenditure on personal care products is also expected to aid in growth of the market. For instance, according to the U.S. Bureau of Labor Statistics, average annual expenditure on personal care products in the U.S. increased from US$ 707 in 2016 to US$ 768 in 2018. Among regions, Asia Pacific is expected to witness significant growth in the online retail market. For instance, according to India Brand Equity Foundation, the e-commerce sector in India is expected to reach US$ 200 billion by 2026 from US$ 38.5 billion as of 2017. The market is also driven by significant growth in the FMCG sector. For instance, according to India Brand Equity Foundation, FMCG market in India is expected to grow at a CAGR of 27.86 per cent and is expected to reach US$ 103.70 billion by 2020 from US$ 52.75 billion in FY18. Read More @ https://coherentmarketinsights-blog.blogspot.com/2020/11/emergence-of-covid-19-to-augment-growth.html

Corporate wellness has been around for many years. However, the emergence of Covid-19 has brought it into the mainstream of organizations. Companies are now looking at ways to improve their workforce's health and well-being. The recent economic crisis and the drastic change in the working environment have both highlighted how imperative it is for companies to develop and sustain a healthy workforce. Corporate wellness programs have become the norm for many US-based companies. According to a report sponsored by U.S. Department of Labor and the U.S. Department of Health and Human Services and produced by The RAND Corporation, over 80% of companies in the U.S with over fifty employees offered some sort of corporate wellness benefit. When most people think of wellness, they often think of physical fitness and nutrition. There are several benefits to improving your employee's mental health and wellbeing as well. Studies show that poor mental health is correlated with work-related and job-related injuries, which in turn can result in lost productivity, higher sick days, and an overall loss in profitability. Read more @ https://coherentmarketinsights-cmi.blogspot.com/2020/12/emergence-of-covid-19-and-focus-on.html

Gouty arthritis is a type of arthritis that causes inflammation, typically in one joint, which begins suddenly. Gouty arthritis is caused by the deposition of needle-shaped crystals of uric acid in a joint. The primary symptoms of gouty arthritis include severe pain, swelling, and redness in joints, often in the big toe. Increasing prevalence of gout with rising alcohol consumption is expected to drive growth of the global gouty arthritis market. According to the Centers for Disease Control and Prevention (CDC), from 2013-2015 around 54.4 million adults in the U.S. have some form of arthritis, gout, rheumatoid arthritis, or fibromyalgia. According to the Arthritis Foundation, 8 million people in the U.S. suffer from gout arthritis every year. According to the same source, high intake of sugary or alcoholic drinks is one of the major risk factors for gout arthritis. Alcohol is a major source of purine, which produces uric acid. High levels of uric acids in the body can result in the formation of crystals of uric acid, eventually leading to gout. Hence, such factors are expected to drugs market is expected to drive growth of the global gouty arthritis market. Furthermore, increasing adoption of biologics and increasing R&D activities in regenerative medicines is expected to propel the global gouty arthritis market growth in the near future. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/02/gouty-arthritis-market-is-gaining.html

Course "Verification vs. Validation - Product Process Software and QMS" has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion. Overview: This course will review the company Master Validation Plan for major key inputs and CGMP deficiencies. It will address the FDA's newer and tougher regulatory stance. This course's aim is to prove "Product Risk Based V&V" by sufficient, targeted and documented risk-based V&V test case elements/scripts. It will teach participants to evaluate its elements against ISO 14971 and ICH Q9 for hazard analysis and product risk management. This course will evaluate different field-tested, U.S. FDA-reviewed V&V protocols; how to employ equipment/process Requirements Specs / DQs, IQs, OQs, and PQs, or their equivalents per ASTM E2500, all against a background of limited company resources. It will review a matrix that simplifies "as-product", in-product", process and equipment, et al, software VT&V, to assure key FDA requirements are not overlooked. While considering the QMS and 21 CFR Part 11; this course will make practical application of these same in two hands-on sessions. Why you should attend: This session helps participants: * Understand Verification and Validation, differences and how they work together; * Discuss recent regulatory expectations; * Know how to document a "risk-based" rationale, and use it in a resource-constrained environment; * Determine key "milestones" and "tasks" in a project; * Locate and document key subject "inputs"; * Compile "generic" Master and Individual Validation Plans; * Learn the key element of a Product V&V File/Protocol; * Understand how to develop Process and/or Production/Test Equipment V&V Files/Protocols; * Get a grasp of basic Test Case construction; * Understand sample sizes and their justification; * Learn the key elements of Software V&V expected by the FDA and how to document; * Deal with hardwa

Cone beam computed tomography is an imaging technique that consists of X-ray computed imaging where the X-rays reflect and diverge, creating a cone-shaped beam. The cones are formed as the rays are deflected by colliding with a mirror and the resulting image is viewed from the inside of the cone. Cone-beam computed imaging uses the power of a computer to create images using the principle of diffraction and is very efficient in obtaining high quality images. Increasing prevalence of dental disorders is expected to propel growth of the global cone beam computed tomography (CBCT) market. For instance, according to the Centers for Diseases Control and Prevention's Oral Health Surveillance Report, 2019, the prevalence of untreated tooth decay in primary teeth was 10% among children aged 2-5 years and 16% among those 6-8 years during 2011-2016. Moreover, approval and launch of new products is also expected to aid in growth of the market. For instance, in December 2018, EhmetDX, received FDA 510(k) clearance for its 3D CBCT positioning software. The software is used to guide the position of proton beams in patient treatments. Increasing geriatric population is expected to offer lucrative growth opportunities for players in the global cone beam computed tomography (CBCT) market. For instance, according to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034. Read more @ https://sachinbhombe.blogspot.com/2021/03/increasing-prevalence-of-dental.html

Autoclaves are also known as steam sterilizers and are used to expose each item to direct steam contact at the required temperature and pressure for the specified time. They are used for healthcare or industrial applications to eliminate the protein structure of the bacteria and spores. Compatible of steam autoclaves for crisis strategy decontamination of N95 respirators is expected to propel growth of the global steam autoclave market. For instance, in October 2020, 3M, a U.S-based multinational conglomerate corporation, announced that Belimed steam autoclaves are compatible for crisis strategy decontamination of specific single-use N95 Respirators. Moreover, launch of biological indicators for steam autoclaves is also expected to aid in growth of the market. For instance, in December 2020, Steris Corporation, a U.S-based medical equipment company, launched Spordex Self-Contained Biological Indicator Ampoules to confirm sterilization of liquids in steam autoclave cycles. Emergence of Covid-19 is expected to offer lucrative growth opportunities for players in the global steam autoclave market. For instance, globally, as of 4:03pm CET, 1 March 2021, there have been 113,820,168 confirmed cases of COVID-19, including 2,527,891 deaths, reported to the World Health Organization. Moreover, high prevalence of hospital-acquired infections is also expected to aid in growth of the market. For instance, according to an observational epidemiological study of intra-abdominal infections published in December 2019, in NEJM Journal Watch, of the 2621 critically ill adults with intra-abdominal infections at 309 international centers between January and December 2016, 32% were community-acquired, while 68% were hospital-acquired. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/03/emergence-of-covid-19-and-lunch-of-new.html

Medical aesthetics is a fairly broad field that covers several different, often overlapping sub-specialties. These include endocrinology, gynecology, pathology, radiology, gastroenterology, health care, obstetrics/maternity, orthopedics, pediatrics, physiology, psychology, statistics, and pharmacology. The field of medical aesthetics is increasingly expanding due to increasing numbers of people who have an interest in looking better and feeling better about their appearance. This interest has resulted in an expansion of the field into several subspecialties, which are described below. One of the top five surgical aesthetic procedures is liposuction. Liposuction is a procedure used to remove pockets of fat from different parts of the body to improve facial features, such as an extra small smile, sagging skin around the eyes or lips, or fat deposits in the neck or waist. Other liposuction procedures include using liposuction to change the size and shape of tattoos, removing skin tags, wart formation on the face, flattening abdominal fat, reshaping the breasts after pregnancy, removing wrinkles, and improving the skin texture around the mouth, chin, and neck. Other surgical aesthetic procedures include laser lipolysis, adjustable gastric banding, lipoplasty, blepharoplasty, neck lift, chin and jowl reduction, laser facial resurfacing, and Botox injections. The main factor influencing the medical aesthetics market is the growing surgical procedures worldwide for advanced personal appearance. For instance, according to the Centers for Disease Control and Prevention, around 130,000 facelifts are performed in the U.S. and the numbers are increasing annually. According to Cosmetic Surgery Solicitors, the U.S. and Brazil accounted for more than 28.4% of cosmetic producers in the world in 2018. The top five surgical procedures that are done across the globe are ear surgery, fat grafting, rhinoplasty, gyne

Chronic lymphocytic leukemia is a cancerous disease in which cancer cells begin to multiply in the lymph cells. CLL is aggressive cancer that invades the lymphatic system and attacks healthy cells of the immune system. It typically affects the lymph nodes and T cells, although it can also affect any other cells in the human body. The combination of chemotherapy is aimed at destroying cancer cells while at the same time allowing the body's immune system to restore the damaged cells. This allows for a more rapid response to the infection and better overall outcomes. As a result of this combination, chemotherapy is often used to treat several types of cancer at one time. It has been very successful in achieving results against most types of cancer. The targeted drugs are given to make the cancer cells unable to multiply and thus stop their growth. Increasing prevalence of leukemia is expected to drive growth of the global chronic lymphocytic leukemia therapeutics market during the forecast period. According to the American Society of Clinical Oncology (ASCO), chronic lymphocytic leukemia (CLL) is the most common type of leukemia in adults aged 19 years and above with 37% of cases. According to the same source, around 21,040 new cases and 4,060 deaths are expected to occur in 2020 due to CLL in the U.S. Furthermore, according to the Leukemia & Lymphoma Society (LLC), in 2020, around 60,530 people are expected to be diagnosed with leukemia in the U.S. Such a high prevalence of CLL and leukemia has increased the demand for necessary therapeutics such as chemotherapy. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/01/chronic-lymphocytic-leukemia.html

Tissue Transplantation products and services are getting widely used in the healthcare sectors worldwide. The term Tissue Transplant refers to the process of adding new tissues to the body that is broken down and replaced by other organs or tissues. It is a major breakthrough in organ transplantation and is used more frequently. Tissue Transplantation is the practice of harvesting and replacing human organs such as kidneys, liver, heart valves, lungs, and bones with other healthy tissues from other people. Tissue Transplantation has given hope to many patients who have had to have a hip replaced or a kidney removed because of disease or illness. In recent years, there has been an increase in the number of people who are now choosing to donate their organs and tissues to medical research and treatment centers. More people are now aware of the need for organ donations and more people are now looking to give back to society than ever before. The demand for organ and tissue transplantation is increasing every day. Unhealthy food habits lack of exercise, drug abuse, and alcohol consumption results in organ failure, owing to which the demand for the Tissue Transplantation products and services market is estimated to rise. Increasing events of acute diseases are also estimated to aid the growth of the market. For instance, high blood pressure and diabetes are the main causes of end-stage renal diseases where kidney dialysis or transplant are the only options to save the patients. According to the U.S. Department of Health & Human Services, in 2019, there were approximately 122,913 patients in U.S. who needed urgent tissue transplants. Hence the increasing demand for advanced transplantation products is estimated to drive the market growth. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/01/the-global-tissue-transplantation.html

A gynecological device is a medical device that is used to promote female health or to protect and preserve reproductive health for females. This is a very broad category and includes products such as watches, calculators, bandages, and hygienic towels. While many of these products have been clinically tested and found to be safe for female health, there are still a few devices in the market that pose threats to female reproductive health. Gynecological devices usually fall into three categories: medical devices, biological safety devices, and mechanical devices. Medical devices are those that prevent the risk of injury or trauma to a woman's reproductive organs from medical interventions. Biologic safety devices are those that protect a female's health by promoting female reproductive health. Finally, mechanical devices are those that help maintain a woman's reproductive health and allow her to achieve or reach their desired fertility or pregnancy. The use of any of these unsupervised or unsafe medical procedures poses a risk to a woman's reproductive health and should be avoided at all costs. The main factors driving the growth of the gynecological devices market are the rapid increase of gynecological diseases such as uterine fibroids, endometriosis, and vaginitis and the introduction of new innovative gynecological devices in the market. For instance, according to the U.S. National Center for Biotechnology Information, approximately 97 per 1000 women suffer from gynecological diseases in the U.S., among which approximately 53 per 1000 women suffer from menstrual disorders. Rising awareness about gynecological health and preventive check-up to avoid sexually transmitted diseases (STD) is expected to boost the market growth. Moreover soaring numbers of surgical procedures such as female sterilization, endoscopy, laparoscopy, and ablation are driving the demand for gynecological devices. However strict regulatory orders by governmental bodies across the globe rel

Cosmetic dentistry is normally used to describe any type of dental work which improves the look of bite, gums, and teeth. It is also commonly used to describe any work done to improve the health of the mouth and to correct any abnormalities. Generally, cosmetic dentistry deals with aesthetic dental surgery, which aims at improving the 'appearance' of the teeth rather than their 'function'. Increasing focus on aesthetic appeal is expected to propel growth of the cosmetic dentistry market. For instance, according to a 2018 survey by Global Data, around three quarters of South Korean men undertake a beauty or grooming treatment at least once a week. Moreover, increasing expenditure on personal care products is also expected to aid in growth of the market. For instance, according to the U.S. Bureau of Labor Statistics, average annual expenditure on personal care products in the U.S. increased from US$ 707 in 2016 to US$ 768 in 2018. Read more @ https://coherentmarketinsights-blog.blogspot.com/2020/12/increasing-focus-on-aesthetic-appeal-to_30.html

Micro guide catheters are used in order to guide the urethra so that you can have an easy time inserting your pet's urethra and not be worried about any kind of blockage at all. There are many types of these devices available in the market. Some of these are manual tube and electric as well. Many people prefer to use micro guide catheters because they are made very simple and with great ease of use. A growing number of surgical procedures for treating cardiovascular diseases is fueling the growth of the micro guide catheters market. According to the American College of Cardiology Foundation, in 2017, emergency medical services-assessed out-of-hospital cardiac arrest occurred in an estimated 356,461 Americans; emergency medical services treatment was initiated in 52%. In the United States in 2019, coronary events are expected to occur in about 1,055,000 individuals, including 720,000 new and 335,000 recurrent coronary events. The increasing development of modern disposable catheters that are safer and more comfortable to insert is further projected to foster the growth of the micro guide catheters market. North America is projected to gain significant growth over the forecast period and this is attributed to the continuous launch of innovative products by ley players in the region. For instance, in March 2017, Teleflex Inc. has announced 510(k) clearance by the U.S. Food and Drug Administration (FDA) and the U.S. commercial launch of the TrapLiner Catheter. The TrapLiner Catheter was developed by Vascular Solutions Inc., which was acquired by Teleflex. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/02/rise-in-number-of-cardiovascular.html

A contrast agent (also called a contrast medium) is an electrically charged material used in medical imaging to enhance the contrast of medical vessels or other tissues in the body. Contrast media/contrast agent either absorbs or changes ultrasound or electromagnetism, which is fundamentally different from radiopharms, which themselves emit electromagnetic radiation. This difference enables contrast agents to be applied to various body tissues with much higher strengths than their non-comp contrast counterparts. The most common contrast media/contrast agent used in medical imaging are CT contrast agents and MRI contrast agents. However, due to their non-magnetic nature, these medical imaging products are not able to be used on organ tissues, such as kidneys, hearts and lungs. Some manufacturers have now started manufacturing non-magnetic, biologically engineered CT and MRI contrast agents called mri-notherapy (mammography, radiofrequency ablation, and ultrasound contrast agents). High prevalence of cancer is expected to boost demand for contrast media. In the U.S., non-magnetic, biologically engineered CT and MRI contrast agents are now being used more frequently to treat patients with benign tumors of all types. Mri-notherapy is used for benign cancers of the breast (breast cancer), abdomen (belly fat), neck, head, joint (arthritis) and spine. Patients with melanoma, anemia, inoperable basilar artery disease, and multiple myeloma are also often treated with mri-notherapy. The therapy has a high success rate for benign tumors and very low incidence of mortality, espeacially in patients undergoing surgery. Moreover, recently, in November 2020, the U.S. FDA approved GE Healthcare's macrocyclic gadolinium-based MRI contrast agent, Clariscan (gadoterate meglumine), in pre-filled syringes. Read more @ https://coherentmarketinsights-cmi.blogspot.com/2020/12/high-prevalence-of-cancer-to-boost.html

The human microbiome is comprised of archaea, eukaryotes, bacteria, and viruses that reside within anatomical sites of the human body including skin, placenta, uterus, mammary glands, lung, saliva, oral mucus, etc. There have been various attempts at understanding the mechanism of this microbiome. The U.S. National Institutes of Health (NIH) launched 'The Human Microbiome Project' to enhance the understanding of microbial flora that is involved in human health and disease. The goals of the project were to reveal the diversity of the microbial community in healthy people, to assess the impact of the environment on the microbiomes of individuals, and to identify new applications for these microbes. The microorganisms in human bodies are an important part of a balanced natural system. This project is a collection of over 100 human microbiomes that was obtained from healthy individuals of the U.S. This reference panel was then compared with the microbiomes from the same individuals' stool samples. Read More @ https://coherentmarketinsights-cmi.blogspot.com/2020/11/human-microbiome-project-is-gaining.html

The growing incidence of viral conjunctivitis cases is driving the growth of the viral conjunctivitis drugs market. According to National Center for Biotechnology: 2017, adenovirus is the most common cause of viral conjunctivitis and up to 70% of cases of acute conjunctivitis are viral. The number of individuals affected by viral conjunctivitis is estimated to be as high as 15 to 20 million per year in the U.S. Additionally, a rising number of research and development activities for enhancing the effectiveness of viral conjunctivitis drugs is again projected to accelerate the growth of the market. For instance, in 2019, iVIEW Therapeutics Inc., a clinical-stage ophthalmology drug development company, announced the dosing of the first patient in Phase II clinical trial. iVIEW Therapeutics Inc. is testing the safety and efficacy of the IVIEW-1201 in patients (age ≥15 years) for the treatment of acute adenoviral conjunctivitis. In 2018, Starpharma Holdings Limited, a company headquartered in Australia, received a patent for SPL7013 ophthalmic drops for viral conjunctivitis from the U.S. Patent and Trademark Office. The patent has been granted to the company due to its broad claims for treating and preventing microbial infections of the eye, including adenoviral conjunctivitis, bacterial conjunctivitis, and other eye infections. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/08/starpharma-holdings-limited-received.html

Anti-counterfeit packaging solutions such as radio-frequency identification (RFID), forensic techniques, 2D barcodes, holograms, and more are used to protect customers from counterfeit products. Secure packaging plays a key role in preventing the counterfeiting of any product. Anti-counterfeiting packaging provides a secure and safe packaging solution to the product, in order to eliminate infringement and counterfeiting. Stringent laws and regulations enforced by governments are expected to drive growth of the global anti-counterfeit packaging market during the forecast period. The government of many countries has enforced stringent regulations and laws to curb the counterfeiting of products. Furthermore, in September 2020, the International Trademark Association (INTA) announced to step up its efforts to combat counterfeit products with new laws under consideration. Moreover, in December 2019, in the U.S., the SANTA Act (Stopping All Nefarious Toys in America Act) was introduced that set requirements for online marketplaces selling toys to verify seller information and disclose it to consumers. Read more @ https://sachinbhombe.blogspot.com/2021/03/anti-counterfeit-packaging-market.html

Metastatic osteosarcoma is one form of the disease osteoarthritis. It has been found that this disease occurs due to a problem with the cells in the spinal cord that are responsible for the proper function of the joints. The disease generally affects the aging group and those individuals suffering from other medical conditions like diabetes etc. The pain caused due to metastatic osteosarcoma can be so severe that it leads to tremendous disability to the affected person. Increasing drug pipeline for malignant bones and soft tissue cancer is expected to drive growth of the global metastatic osteosarcoma treatment market. Key biopharmaceutical and pharmaceutical companies are focused on research and development activities to synthesize novel drug treatment for soft tissue and malignant bone cancer. For instance, in September 2020, Junshi Biosciences, a major biopharmaceutical company, received the U.S. Food and Drug Administration (FDA) Orphan Drug designation to Toripalimab for the treatment of soft tissue sarcoma. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/03/metastatic-osteosarcoma-treatment.html